Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed...
Keep Reading →
December 16 - Hedge Funds, News - Comments
In this article we will take a look at whether hedge funds think PDL BioPharma Inc. (NASDAQ:PDLI) is a good investment right now. We check hedge fund...
Keep Reading →
June 27 - Hedge Funds, News - Comments
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data....
Keep Reading →
December 10 - Hedge Funds, News - Comments
Is PDL BioPharma Inc. (NASDAQ:PDLI) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research...
Keep Reading →
October 31 - Hedge Funds, News - Comments
Hedge funds are not perfect. They have their bad picks just like everyone else. Facebook, a stock hedge funds have loved dearly, lost nearly 40% of its...
Keep Reading →
June 20 - Hedge Funds, News - Comments
How do you pick the next stock to invest in? One way would be to spend hours of research browsing through thousands of publicly traded companies. However...
Keep Reading →
May 12 - Hedge Funds, News - Comments
Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Amazon, Facebook and Alibaba, have not done well in October...
Keep Reading →
December 23 - Hedge Funds, News - Comments
Here’s a breakdown on how the Magic Formula Portfolio is performing. Since beginning this Shadow Stock Portfolio on June 1, 2016, it owns six stocks...
Keep Reading →
December 9 - News, Stock Analysis - Comments
There are several ways to beat the market, and investing in small cap stocks has historically been one of them. We like to improve the odds of beating...
Keep Reading →
December 2 - Hedge Funds, News - Comments
Here’s a breakdown on how the Enterprising Investor Portfolio is performing. Since beginning this Shadow Stock Portfolio on June 1, 2016, it owns...
Keep Reading →
November 11 - News, Stock Analysis - Comments
We, at Insider Monkey, have gone over 700 13F filings that hedge funds and prominent investors are required to file by the government. The 13F filings...
Keep Reading →
November 25 - Hedge Funds, News - Comments
One of the funds we track is Joel Greenblatt‘s Gotham Asset Management, which recently filed its 13F form, disclosing its equity portfolio as at...
Keep Reading →
November 15 - Hedge Funds, News - Comments
Editor’s Note: Vringo, Inc. (NASDAQ:VRNG), Google Inc (NASDAQ:GOOG), AOL, Inc. (NYSE:AOL), Marathon Patent Group Inc (OTCBB:MARA). Target Corporation...
Keep Reading →
September 6 - News - Comments
If you were to ask many market players, hedge funds are assumed to be overrated, old investment vehicles of a forgotten age. Although there are more than...
Keep Reading →
September 4 - News - Comments
Should PDL BioPharma Inc. (NASDAQ:PDLI) investors track the following data? In the eyes of many market players, hedge funds are seen as overrated, old...
Keep Reading →
September 3 - News - Comments
What’s a smart Puma Biotechnology Inc (NYSE:PBYI) investor to do? In today’s marketplace, there are dozens of methods market participants can...
Keep Reading →
September 3 - News - Comments
What should a smart Santarus, Inc. (NASDAQ:SNTS) investor do? In the financial world, there are a multitude of gauges investors can use to watch publicly...
Keep Reading →
August 30 - News - Comments
Are you curious what the richest investors think about VIVUS, Inc. (NASDAQ:VVUS)? In the 21st century investor’s toolkit, there are dozens of metrics...
Keep Reading →
August 22 - News - Comments
MannKind Corporation (NASDAQ:MNKD) has gotten one of the biggest votes of confidence we’ve seen from the smart money, out of the entire stock market...
Keep Reading →
August 22 - News - Comments
The biotech industry is known for fast paced acquisitions and rapid market consolidation. Larger pharmaceutical companies headed towards patent cliffs...
Keep Reading →
July 29 - News - Comments
When screening for health-care dividend stocks, it’s tempting to look for the ones with the highest yield. On the surface, larger dividend payments...
Keep Reading →
July 5 - News - Comments
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) investors should pay attention to an increase in activity from the world’s largest hedge funds recently...
Keep Reading →
June 21 - News - Comments
MannKind Corporation (NASDAQ:MNKD) investors should pay attention to a decrease in hedge fund interest recently. According to most stock holders, hedge...
Keep Reading →
June 14 - News - Comments
Is Puma Biotechnology Inc (NYSE:PBYI) a buy here? Hedge funds are betting on the stock. The number of bullish hedge fund bets improved by 2 lately. In...
Keep Reading →
June 10 - News - Comments
Celldex Therapeutics, Inc. (NASDAQ:CLDX) investors should be aware of an increase in hedge fund interest lately. In the financial world, there are plenty...
Keep Reading →
June 6 - News - Comments
This article is removed because of technical problems
Keep Reading →
June 4 - News - Comments
Is PDL BioPharma Inc. (NASDAQ:PDLI) a bargain? Investors who are in the know are taking a pessimistic view. The number of long hedge fund bets fell by...
Keep Reading →
June 4 - News - Comments
Santarus, Inc. (NASDAQ:SNTS) investors should pay attention to a decrease in hedge fund interest in recent months. If you’d ask most shareholders...
Keep Reading →
June 3 - News - Comments
Keeping a close eye on two particular classes of investors can tell you a lot about how stocks might move in the future. Institutional investors have...
Keep Reading →
May 23 - News - Comments
Combining nice dividends with a growing industry that comprises roughly one-fifth of the nation’s GDP should make for an attractive stock —...
Keep Reading →
May 15 - News - Comments
California-based Theravance Inc (NASDAQ:THRX)’s announcement that it would split into two distinct companies has drawn a sharply positive reaction...
Keep Reading →
May 15 - News - Comments
If pharmaceutical companies can break up, why not biotech companies? Following in the footsteps of Abbott Laboratories (NYSE:ABT) spinning out its drug...
Keep Reading →
April 26 - News - Comments
MannKind Corporation (NASDAQ:MNKD) was in 8 hedge funds’ portfolio at the end of December. MNKD shareholders have witnessed an increase in hedge...
Keep Reading →
April 13 - News - Comments
PDL BioPharma Inc. (NASDAQ:PDLI) has experienced a decrease in hedge fund interest recently. In the 21st century investor’s toolkit, there are a multitude...
Keep Reading →
April 2 - News - Comments
With interest rates still sitting near record lows, investors looking for current income have been forced to move from fixed-income positions and into...
Keep Reading →
March 14 - News - Comments
Dividend investing is popular again. Investors have taken to heart Jeremy Siegel’s studies, which show that higher-yielding stocks tend to offer...
Keep Reading →
March 8 - News - Comments
Elan Corporation, plc (ADR) (NYSE:ELN) was nice enough to give us a little more detail on what it plans to do with the $3.25 million that the biotech...
Keep Reading →
February 25 - News - Comments